BETH BANKER: Open Payments
NPI 1538116405 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 68 payments from 19 companies in 2025. Trend: 2023 $1,237 · 2024 $1,324 · 2025 $1,567
Food & beverage: $1,536Education: $30
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $206 |
| Janssen Biotech, Inc. | 10 | $202 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $186 |
| ABBVIE INC. | 12 | $180 |
| Ethicon US, LLC | 1 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $126 |
| PFIZER INC. | 5 | $93 |
| Ipsen Biopharmaceuticals, Inc | 3 | $75 |
| GENZYME CORPORATION | 3 | $74 |
| Lilly USA, LLC | 3 | $63 |
Products named: IBSRELA, TREMFYA, XIFAXAN, LINX REFLUX MANAGEMENT SYSTEM, ENTYVIO, RINVOQ, IQIRVO, DUPIXENT.
Industry payments across VA — which companies pay providers there.
